Cargando…
Anti-HCMV activity by an irreversible p97 inhibitor LC-1310
The AAA+ (ATPase associated with various cellular activities) protein p97, also called valosin-containing protein, is a hexameric ring ATPase and uses ATP hydrolysis to unfold or extract proteins from biological complexes. Many cellular processes are affected by p97 including ER-associated degradati...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794631/ https://www.ncbi.nlm.nih.gov/pubmed/33456290 http://dx.doi.org/10.1007/s00044-020-02679-1 |
_version_ | 1783634255310487552 |
---|---|
author | Wang, Yan Soto-Acosta, Ruben Ding, Rui Chen, Liqiang Geraghty, Robert J. |
author_facet | Wang, Yan Soto-Acosta, Ruben Ding, Rui Chen, Liqiang Geraghty, Robert J. |
author_sort | Wang, Yan |
collection | PubMed |
description | The AAA+ (ATPase associated with various cellular activities) protein p97, also called valosin-containing protein, is a hexameric ring ATPase and uses ATP hydrolysis to unfold or extract proteins from biological complexes. Many cellular processes are affected by p97 including ER-associated degradation, DNA damage response, cell signaling (NF-κB), cell cycle progression, autophagy, and others. Not surprisingly, with its role in many fundamental cellular processes, p97 function is important for the replication of many viruses. We tested irreversible p97-targeting compounds for their ability to inhibit the replication of multiple viruses compared to the known p97 inhibitors NMS-873 and CB-5083. Our results indicate that overall cellular toxicity for p97 compounds provides a challenge for antivirals targeting p97. However, we identified one compound with sub-micromolar activity against human cytomegalovirus and improved cell viability to provide evidence for the potential of irreversible p97 inhibitors as antivirals. [Image: see text] |
format | Online Article Text |
id | pubmed-7794631 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-77946312021-01-11 Anti-HCMV activity by an irreversible p97 inhibitor LC-1310 Wang, Yan Soto-Acosta, Ruben Ding, Rui Chen, Liqiang Geraghty, Robert J. Med Chem Res Original Research The AAA+ (ATPase associated with various cellular activities) protein p97, also called valosin-containing protein, is a hexameric ring ATPase and uses ATP hydrolysis to unfold or extract proteins from biological complexes. Many cellular processes are affected by p97 including ER-associated degradation, DNA damage response, cell signaling (NF-κB), cell cycle progression, autophagy, and others. Not surprisingly, with its role in many fundamental cellular processes, p97 function is important for the replication of many viruses. We tested irreversible p97-targeting compounds for their ability to inhibit the replication of multiple viruses compared to the known p97 inhibitors NMS-873 and CB-5083. Our results indicate that overall cellular toxicity for p97 compounds provides a challenge for antivirals targeting p97. However, we identified one compound with sub-micromolar activity against human cytomegalovirus and improved cell viability to provide evidence for the potential of irreversible p97 inhibitors as antivirals. [Image: see text] Springer US 2021-01-09 2021 /pmc/articles/PMC7794631/ /pubmed/33456290 http://dx.doi.org/10.1007/s00044-020-02679-1 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Research Wang, Yan Soto-Acosta, Ruben Ding, Rui Chen, Liqiang Geraghty, Robert J. Anti-HCMV activity by an irreversible p97 inhibitor LC-1310 |
title | Anti-HCMV activity by an irreversible p97 inhibitor LC-1310 |
title_full | Anti-HCMV activity by an irreversible p97 inhibitor LC-1310 |
title_fullStr | Anti-HCMV activity by an irreversible p97 inhibitor LC-1310 |
title_full_unstemmed | Anti-HCMV activity by an irreversible p97 inhibitor LC-1310 |
title_short | Anti-HCMV activity by an irreversible p97 inhibitor LC-1310 |
title_sort | anti-hcmv activity by an irreversible p97 inhibitor lc-1310 |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794631/ https://www.ncbi.nlm.nih.gov/pubmed/33456290 http://dx.doi.org/10.1007/s00044-020-02679-1 |
work_keys_str_mv | AT wangyan antihcmvactivitybyanirreversiblep97inhibitorlc1310 AT sotoacostaruben antihcmvactivitybyanirreversiblep97inhibitorlc1310 AT dingrui antihcmvactivitybyanirreversiblep97inhibitorlc1310 AT chenliqiang antihcmvactivitybyanirreversiblep97inhibitorlc1310 AT geraghtyrobertj antihcmvactivitybyanirreversiblep97inhibitorlc1310 |